PMID- 23885515 OWN - NLM STAT- MEDLINE DCOM- 20130816 LR - 20221207 IS - 0091-2174 (Print) IS - 0091-2174 (Linking) VI - 44 IP - 4 DP - 2012 TI - Depression ratings and antidepressant use among outpatient heart failure patients: implications for the screening and treatment of depression. PG - 315-34 AB - OBJECTIVE: To investigate the characteristics of antidepressant use among heart failure (HF) outpatients. METHODS: Self-reported data on antidepressant use, Beck Depression Inventory (BDI) ratings, and demographics, as well as HF diagnosis severity, was collected from 218 New York Heart Association (NYHA) Classes I-IV HF outpatients (mean age 57.29 years). RESULTS: The overall prevalence of depressive symptoms (BDI > 10) was 43.1% (n = 94); 23.4% had a prior diagnosis of depression. Thirty-three percent of patients were taking antidepressants but, despite this treatment, 64% still showed at least mild-moderate depressive symptoms (BDI > or = 10) compared to 34% of patients not currently receiving antidepressants (p = 0.05). When asked if their mood had improved as a result of antidepressant therapy, 45% reported responses ranging from "halfway back to normal" to no improvement at all; BDI scores were related to self-reports of how well antidepressant therapy affected patient's mood (p < .01). Among patients receiving antidepressants (primarily SSRIs), 26% did not have a formal depression diagnosis prior to receiving antidepressants, and 39.1% reported never having had a dose adjustment in antidepressant medication. Similar numbers of patients were prescribed antidepressants by primary care physicians as mental health providers, while much fewer cardiologists prescribed antidepressants. CONCLUSIONS: Findings provide insight into practice and provider patterns related to antidepressant use in HF. HF patients treated with antidepressants still show high rates of depressed mood, and follow-up and monitoring of effectiveness of antidepressant therapy needs attention. Effective treatment of depression could support improved clinical outcomes and better quality of life for HF patients. FAU - Jimenez, Jessica A AU - Jimenez JA AD - SDSU/UCSD Joint Doctoral Program in Public Health and University of California, San Diego. La Jolla, CA, USA. FAU - Redwine, Laura L AU - Redwine LL FAU - Rutledge, Thomas R AU - Rutledge TR FAU - Dimsdale, Joel E AU - Dimsdale JE FAU - Pung, Meredith A AU - Pung MA FAU - Ziegler, Michael G AU - Ziegler MG FAU - Greenberg, Barry H AU - Greenberg BH FAU - Mills, Paul J AU - Mills PJ LA - eng GR - HL-079891/HL/NHLBI NIH HHS/United States GR - R01 HL073355/HL/NHLBI NIH HHS/United States GR - HL-57265/HL/NHLBI NIH HHS/United States GR - UL1TR00100/TR/NCATS NIH HHS/United States GR - HL-073355/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PL - United States TA - Int J Psychiatry Med JT - International journal of psychiatry in medicine JID - 0365646 RN - 0 (Antidepressive Agents) RN - 0 (Serotonin Uptake Inhibitors) SB - IM MH - Antidepressive Agents/*therapeutic use MH - Comorbidity MH - Depression/diagnosis/*drug therapy/*epidemiology MH - Disease Management MH - Female MH - Heart Failure/*drug therapy/*epidemiology MH - Humans MH - Male MH - Mass Screening/methods MH - Middle Aged MH - Outpatients/psychology MH - Prevalence MH - Psychiatric Status Rating Scales MH - Selective Serotonin Reuptake Inhibitors/therapeutic use MH - Severity of Illness Index MH - Treatment Outcome EDAT- 2012/01/01 00:00 MHDA- 2013/08/21 06:00 CRDT- 2013/07/27 06:00 PHST- 2013/07/27 06:00 [entrez] PHST- 2012/01/01 00:00 [pubmed] PHST- 2013/08/21 06:00 [medline] AID - 10.2190/PM.44.4.c [doi] PST - ppublish SO - Int J Psychiatry Med. 2012;44(4):315-34. doi: 10.2190/PM.44.4.c.